Glycosylation Patterns of HIV-1 gp120 Depend on the Type of Expressing Cells and Affect Antibody Recognition
Open Access
- 1 July 2010
- journal article
- Published by Elsevier BV in Online Journal of Public Health Informatics
- Vol. 285 (27), 20860-20869
- https://doi.org/10.1074/jbc.m109.085472
Abstract
No abstract availableThis publication has 73 references indexed in Scilit:
- Genetic identity, biological phenotype, and evolutionary pathways of transmitted/founder viruses in acute and early HIV-1 infectionThe Journal of Experimental Medicine, 2009
- Challenges in the development of an HIV-1 vaccineNature, 2008
- Analysis of IgA1 N-Glycosylation and Its Contribution to FcαRI BindingBiochemistry, 2008
- Identification and characterization of transmitted and early founder virus envelopes in primary HIV-1 infectionProceedings of the National Academy of Sciences of the United States of America, 2008
- Delivery of DNA HIV-1 vaccine to the liver induces high and long-lasting humoral immune responsesVaccine, 2008
- Glycosylation Site-Specific Analysis of HIV Envelope Proteins (JR-FL and CON-S) Reveals Major Differences in Glycosylation Site Occupancy, Glycoform Profiles, and Antigenic Epitopesʼ AccessibilityJournal of Proteome Research, 2008
- Cross-subtype antibody and cellular immune responses induced by a polyvalent DNA prime–protein boost HIV-1 vaccine in healthy human volunteersVaccine, 2008
- Human immunodeficiency virus-like particles activate multiple types of immune cellsVirology, 2007
- Antigenicity and immunogenicity of HIV-1 consensus subtype B envelope glycoproteinsVirology, 2007
- Structural definition of a conserved neutralization epitope on HIV-1 gp120Nature, 2007